and a discontinued oral GLP-1 programme (danuglipron) that was terminated in late 2023 due to gastrointestinal tolerability issues that prevented adequate dose escalation
The events manifested soon after the initiation of GLP-1 RA treatment, with a median onset time of 92 days (range: 03,312, n = 1,591) across all ICSRs that provided both drug initiation and AP onset times
Transport of glutathione, glutathione disulfide, and glutathione conjugates across the [PMID: 2779439] Laboratory literature summary: Transport of glutathione, glutathione disulfide, and glutathione conjugates across the hepatocyte plasma membrane
Importantly, the expression level of the synaptic protein synaptophysin was much improved in the hippocampus and the neocortex, documenting that the synaptic loss that is common for this AD animal model has been reduced by liraglutide
Whilst retatrutide is not yet licensed in the UK, its pharmacological profile particularly its effect on slowing gastric emptying and reducing appetite has implications for how certain foods, supplements, and substances may interact with the medicine